Ingevity reports second quarter 2026 financial results

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports second quarter 2026 financial results Second Quarter 2026 Results and Recent Highlights: • Net sales of $314.1 million decreased 5% from prior year; exc

Original reporting
Published Jul 29, 2026, 9:18 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 29, 2026, 9:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$NGVT
Bullish
high confidence
Mentioned
$NGVT
Relevance
7/10
AlphAI data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$NGVTBullishMed
01

Why it matters

The key tradable elements are the raised full-year adjusted EBITDA range, improved adjusted EBITDA margin, and stated leverage improvement, partially offset by negative operating cash flow due to a litigation settlement payment.

02

Market read

Guidance and profitability metrics provide a fresh decision point for positioning ahead of the July 30 webcast and subsequent earnings expectations.

03

What to watch

Segment volatility remains: Pavement Technologies sales declined 22% and Advanced Polymer Technologies EBITDA margin surged from 4.6% to 22.7%, so traders may watch for sustainability versus one-time drivers like competitor supply disruptions and boiler downtime effects.

Relevance 7/10Novelty 8/10Timing: after-hours following the Q2 2026 8-K and guidance raise

Background

This is an SEC Form 8-K (Item 2.02) with Q2 2026 financial results and an updated full-year 2026 outlook, including the impact of the April 15, 2026 Road Markings divestiture.

Company-level read

Ticker impact

$NGVTBullishHigh confidence
Context

Ingevity reports Q2 2026 results and raises full-year adjusted EBITDA outlook to $380 to $400 million after a Road Markings divestiture.

Expected impact

Likely positive near-term bias as guidance is increased and divestiture effects clarify segment outlook.

Evidence & confidence

The filing includes specific Q2 datapoints (adjusted EBITDA $115.0m, margin 36.6%) and a concrete full-year adjusted EBITDA range increase, plus stated leverage improvement and planned use of free cash flow.

Market effects

Signals demand and pricing resilience in Performance Materials and improving profitability in Advanced Polymer Technologies, while Pavement Technologies remains pressured by divestiture and regional weakness.

Notes regional strength in North America but weakness in China and South America within Pavement Technologies, which may affect regional read-through for similar materials suppliers.

PFAS filtration contract mention supports ongoing investment interest in carbon technologies, though it is framed as early validation rather than quantified revenue.

Counterpoint

The guidance raise is paired with measured second-half outlook and negative operating cash flow driven by a litigation settlement, which could temper enthusiasm.

Key entities

  • Ingevity Corporation

    Reports Q2 2026 results, completes Road Markings divestiture, and raises full-year adjusted EBITDA outlook.

Related articles

$NGVTMed

Ingevity (NGVT) Lifted EPS Guidance, Is The Stock Still Cheap?

Ingevity (NGVT) raised its full-year EPS guidance despite lower Q3 sales. The stock has fallen 15.34% in the past week but remains up 25.15% over one year. Analysts estimate fair value at $89, suggesting a 30% undervaluation, though its P/E ratio is higher than industry averages. The company plans $300M in share buybacks by 2027.

$NGVTHighAI 8/10

Ingevity Q3 Earnings Call Highlights

Ingevity (NGVT) reports Q3 earnings, highlighting growth in hybrid vehicle and filtration markets. CEO Dave Li notes benefits from the hybrid transition and new water treatment contracts. Pavement Technologies sales fell 24% due to divestiture and higher asphalt costs. Advanced Polymer Technologies sales rose 18%. The company narrowed its 2026 adjusted EBITDA outlook to $385M-$395M and expects $1.1B in sales. Ingevity repurchased $39M in shares during Q3.

$NGVTMed

Ingevity (NGVT) Q3 2026 Earnings Call Transcript

Ingevity (NGVT) reported Q3 2026 sales of $305M, down 8% YoY due to divestitures, but up 2% excluding them. Adjusted EBITDA was $108M, down 2%, with margins expanding to 35.4%. EPS rose 24% to $1.63. The company highlighted growth in filtration and water treatment, secured new contracts, and repurchased $39M in shares. Full-year adjusted EBITDA is expected to be $385M-$395M, with sales around $1.1B and EPS of $5.25-$5.45.

$NGVTMed

Ingevity reports third quarter 2026 financial results

Ingevity Corp (NGVT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Ingevity Corporation 4920 O'Hear Avenue Suite 400 North Charleston, SC 29405 USA www.ingevity.com Ingevity reports third quarter 2026 financial results Third Quarter 2026 Results and Recent Highlights: • Net sales of $305.1 million decreased 8% from prior year; exclu

$NGVTHigh

Ingevity reports third quarter 2026 financial results

Ingevity reported Q3 2026 net sales of $305.1M, down 8% YoY. Net income rose to $51.1M per diluted share. Adjusted EBITDA fell $108M but margin expanded to 35.4%. The company narrowed its full-year adjusted EBITDA outlook to $385M-$395M. CEO Dave Li cited strong Performance Materials but noted challenges in Pavement Technologies. Ingevity (NYSE: NGVT) plans to host an earnings call on November 5, 2026.